Rotech Bondholders Want Baker & McKenzie Fees Capped

Law360, New York (May 15, 2013, 4:44 PM ET) -- Rotech Healthcare Inc.’s bondholders on Wednesday echoed the bankrupt medical equipment maker’s opposition to the retention of Baker & McKenzie LLP on an hourly basis as counsel for the official equity committee, saying the firm should only be compensated by a contingent fee.

Capital Research and Management Co., Fidelity Investments, Silver Point Capital LP and Venor Capital Management LP, as holders of approximately $290 million in second lien notes, said until creditors are paid in full, counsel for the equity committee should either work on a...
To view the full article, register now.